-
CommerceBlitz
Hugh SinclairDone
-
Neman Ventures
Shane NemanDone
-
Vitranu
Gordon BethwaiteDone
-
TAM-C Solutions
Aaron RichmanDone
-
Ricovr
Piyush SadanaDone
-
Sovany
Marcella FodorDone
-
Oberit
Will HouseDone
-
Simple Ideas
Mitchell TateDone
-
IM Financial
Rodrigo Acuna CervantesDone
-
Small Eyes
David SiegelDone
Dr. Gaytri Kachroo is an accomplished legal scholar with a PhD from the Harvard Law School. Dr. Kachroo is a highly accomplished general counsel and has acted in senior executive management roles for the past 20 years in biopharma and finance. Prior successes have been marked in her experience as a high-profile congressional counsel, fraud litigator, international regulatory experience, and as corporate transactional attorney in technology, life sciences, and finance.
Arise BioPharma Inc. (Arise) is a wholly-owned subsidiary of Peptide Account LLC. Arise holds property rights to several late-stage compounds targeting neuro-degenerative illnesses. It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.